Ashwagandha (Withania somnifera) capsules are almost always sold by root-extract weight, not by active-compound content — and that gap is the single biggest thing separating a clinically dosed product from a placebo-strength one. A 2012 randomized, double-blind, placebo-controlled trial found a 27.9% drop in serum cortisol at 300 mg twice daily of a standardized extract, versus 7.9% for placebo, but "standardized" is the operative word most labels quietly skip.
Ashwagandha is an Ayurvedic adaptogenic root with genuine randomized-trial support for stress, cortisol, sleep, and male fertility markers — but the effect sizes reported in research were produced by extracts standardized to a specific withanolide percentage (5% for KSM-66, 10% for Sensoril), not by root powder alone. A capsule labeled only in milligrams of "ashwagandha extract" with no withanolide percentage could contain a fraction of the active compound used in the trials. Checking that one number on the label is the single highest-leverage thing a buyer can do.
Ashwagandha has moved from a niche Ayurvedic herb to one of the most searched adaptogens in the supplement aisle, and the research base has genuinely grown alongside the marketing. That's unusual — most trending botanicals outrun their evidence. Ashwagandha mostly hasn't, provided you're looking at the right dose and the right extract.
What Is Ashwagandha (Withania Somnifera)?
Withania somnifera is a small shrub in the nightshade family, native to India, the Middle East, and parts of Africa, where its root has been used in Ayurvedic medicine for centuries as a "rasayana" — a rejuvenative tonic taken for general resilience rather than one specific complaint. The common name translates roughly to "smell of horse," a reference to the root's odor and, traditionally, to the vitality it was believed to confer.
Modern research has narrowed that broad traditional use into a few specific, testable claims: lower cortisol under chronic stress, improved subjective sleep quality, and measurable changes in male reproductive hormones. Those three areas now have the most randomized-trial support of anything in the plant's traditional repertoire.
What Does "Withanolides" Actually Mean on a Label?
Withanolides are the steroidal lactone compounds believed to drive most of ashwagandha's pharmacological activity, and clinical trials standardize their extracts to a specific withanolide percentage rather than dosing raw root powder by weight. KSM-66, the extract used in the largest cortisol and sleep trials, is standardized to 5% withanolides from root only; Sensoril, a root-and-leaf extract, is standardized to 10% withanolides plus 32% oligosaccharides.
This is why two bottles that both say "600 mg ashwagandha" are not interchangeable. A generic root powder with no stated withanolide percentage could sit well under 1%, meaning a 600 mg capsule delivers a fraction of the withanolide load used in any published trial. The withanolide percentage, not the milligram total, is the number that actually maps to research dosing — and it's the one most consumer labels omit entirely.
Does Ashwagandha Actually Lower Cortisol?
Yes, with real trial support: a 2012 randomized, double-blind, placebo-controlled study of 64 chronically stressed adults found serum cortisol fell 27.9% after 60 days of 300 mg KSM-66 extract taken twice daily, compared with a 7.9% reduction in the placebo group. A separate 2019 trial using a different standardized extract (Shoden, dosed once daily) also found significantly greater reductions in morning cortisol versus placebo.
What the evidence does not clearly support is a parallel drop in perceived stress at the same magnitude. A meta-analysis pooling eight randomized trials in 488 adults found ashwagandha reduced measured cortisol but did not produce a matching reduction in self-reported stress ratings — a meaningful distinction between a biomarker moving and a person actually feeling calmer.
What About Sleep, Testosterone, and Fertility Claims?
A 2019 double-blind, placebo-controlled trial in 60 adults found significant improvement in sleep onset latency, sleep efficiency, and Pittsburgh Sleep Quality Index scores after 10 weeks of 300 mg KSM-66 extract, alongside reduced anxiety scores on the same protocol. The effect was present in participants without diagnosed insomnia too, though it was more pronounced in those who started with poorer sleep.
On male fertility, a 2013 pilot study of 46 men with oligospermia (low sperm count) found 90 days of 675 mg daily root extract produced a 167% increase in sperm count, a 53% increase in semen volume, a 57% increase in sperm motility, and a 17% increase in serum testosterone versus placebo. That's a genuinely large effect size, but it comes from one small pilot study in a specifically infertile population — it doesn't establish the same magnitude of change in men with normal baseline fertility, and it hasn't been replicated at that scale since.
How Much Ashwagandha Do Studies Actually Use?
Most positive trials cluster in the 300 mg to 600 mg per day range of a standardized root extract, typically split into two doses, taken over 8 to 12 weeks before assessing outcomes. The fertility study used a higher 675 mg daily dose split three ways, and the thyroid study below used 600 mg once daily.
Results consistently take weeks, not days — every trial cited here ran 8 weeks or longer before measuring outcomes, which matters for anyone expecting an immediate effect. Combining ashwagandha with an adaptogenic mushroom stack follows the same logic: consistency over 8–12 weeks, not a single dose, is what the evidence is actually measuring.
KSM-66 vs. Sensoril vs. Plain Root Powder
KSM-66 is a root-only extract preserving the plant's natural withanolide ratio at a 5% standardization, and it's the extract behind the cortisol, sleep, and most stress-related trials cited above. Sensoril is a root-and-leaf extract standardized to a higher 10% withanolide content plus oligosaccharides, typically dosed lower (125–250 mg) for a comparable withanolide load.
Plain, non-standardized root powder is the least predictable option: without a stated withanolide percentage, there's no way to know whether a given batch resembles the extracts used in research at all, since withanolide content varies naturally with the plant's growing conditions, harvest timing, and which part of the root is used. That variability is exactly what reading a supplement label properly is meant to catch before you buy.
Safety, Interactions, and Who Should Avoid It
Ashwagandha carries real, documented risks that go beyond the standard "consult your doctor" boilerplate. A 2020 case series in Liver International described five patients — three from Iceland, two from the US Drug-Induced Liver Injury Network — who developed cholestatic or mixed-pattern liver injury with jaundice after 2–12 weeks of ashwagandha use; all recovered without transplant, but the pattern was consistent enough across five independent cases to be taken seriously.
A separate 2018 randomized trial found 600 mg daily measurably raised T3 and T4 and lowered TSH in subclinical hypothyroid patients over 8 weeks — a helpful effect for that specific population, but a real concern for anyone with hyperthyroidism or Graves' disease, where pushing thyroid hormone higher is the opposite of what's needed. Ashwagandha is also classified as an abortifacient in traditional Ayurvedic texts and is not recommended during pregnancy under modern guidance. It should not be combined with sedatives, thyroid medication, or immunosuppressants without medical supervision, and anyone with an autoimmune condition should discuss it with a doctor before starting, since it can stimulate immune activity.
Frequently Asked Questions
How long does ashwagandha take to work?
Published trials measured effects at 8 to 12 weeks of consistent daily use, not days. The 2019 sleep trial and 2012 cortisol trial both ran 60–70 days before assessing outcomes, so short-term use is unlikely to reproduce the researched effects.
Is KSM-66 better than regular ashwagandha powder?
KSM-66 is standardized to 5% withanolides and is the specific extract behind most cortisol and sleep trials. Plain root powder without a stated withanolide percentage has no such guarantee and has been shown to vary widely in active-compound content between batches.
Can ashwagandha affect the liver?
Yes. A 2020 case series in Liver International documented five cases of cholestatic or mixed-pattern liver injury linked to ashwagandha supplements, with jaundice appearing 2–12 weeks after starting use. All five recovered without transplant, but the pattern warrants stopping use and seeking care if jaundice or unusual fatigue develops.
Should people with thyroid conditions take ashwagandha?
It depends on the direction of the imbalance. A 2018 trial found ashwagandha raised T3 and T4 in subclinical hypothyroid patients, which helps an underactive thyroid but is a real concern for hyperthyroidism, where hormone levels are already elevated.
Does ashwagandha interact with mushroom supplements like Reishi?
No adverse interaction is documented, and the two are commonly stacked for a broader adaptogenic effect — ashwagandha's cortisol-lowering action paired with Reishi's own stress-resilience research. As with any stack, introduce one at a time to track individual response.
Shop Ashwagandha
Browse our KSM-66 Ashwagandha root extract capsules, or see the full range at amanitamuscariastore.online. Free shipping on orders over €50.
Related Articles
- Reishi and Stress Resilience: What the Research Shows
- Best Mushroom Supplement for Sleep
- How to Stack Mushroom Supplements Safely
- How to Read a Supplement Label
Sources
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. PMC3573577
- Langade D, Kanchi S, Salve J, et al. Efficacy and Safety of Ashwagandha Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus. 2019;11(9):e5797. PMC6827862
- Ambiye VR, Langade D, Dongre S, et al. Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha in Oligospermic Males: A Pilot Study. Evid Based Complement Alternat Med. 2013;2013:571420. PMC3863556
- Björnsson HK, Björnsson ES, Avula B, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829. PubMed 31991029
- Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. J Altern Complement Med. 2018;24(3):243-248. PubMed 28829155